Fidelity Investments
BNTC icon

Fidelity Investments’s Benitec Biopharma BNTC Stock Holding History

Fidelity Investments’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$69.8K Buy
5,216
+3,562
+215% +$42.3K ﹤0.01% 4160
2026
Q1 		$17.6K Buy
1,654
+343
+26% +$3.97K ﹤0.01% 4565
2025
Q4 		$17.7K Buy
1,311
+110
+9% +$1.52K ﹤0.01% 4517
2025
Q3 		$16.9K Buy
1,201
+1,021
+567% +$13K ﹤0.01% 4413
2025
Q2 		$2.11K Buy
+180
New +$2.52K ﹤0.01% 4851

Other funds holding BNTC

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return

Fidelity Investments's BNTC Position: Q2 2026 in Review

Fidelity Investments increased its Benitec Biopharma (BNTC) stake by 215% in Q2 2026, buying an estimated $42.3K and bringing the position to 5,216 shares worth $69.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4160.

Fidelity Investments first reported a position in BNTC in Q2 2025 and has held it in 5 quarters since. 86 funds tracked by Wall St. Rank hold BNTC as of Q2 2026.

  • Fidelity Investments held 5,216 shares of Benitec Biopharma worth $69.8K as of Q2 2026.
  • Fidelity Investments bought 3,562 Benitec Biopharma shares in Q2 2026, an estimated $42.3K.
  • Benitec Biopharma made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #4160 holding.
  • Fidelity Investments first reported a position in Benitec Biopharma in Q2 2025 and has held it in 5 quarters since.
  • 86 funds tracked by Wall St. Rank held Benitec Biopharma as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.